Dementia, Frontotemporal
14
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia
Rural Dementia Caregiver Project
Investigating Genetic Status in Patients Presenting to Clinic
Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
Multifactorial Approach to Dementia, Multicentric Study
SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and Dementia
Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study